Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

237
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
237
Brain Imaging01:14

Brain Imaging

225
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
225
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

63
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
63
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel epigenetic loci identified from an epigenome-wide association study underlying brain structural changes in bipolar disorder.

Psychological medicine·2026
Same author

Decreased cortical gyrification in major depressive disorder.

Psychological medicine·2023
Same author

How Inflammation Affects the Brain in Depression: A Review of Functional and Structural MRI Studies.

Journal of clinical neurology (Seoul, Korea)·2021
Same author

Decreased cortical gyrification in patients with bipolar disorder.

Psychological medicine·2020
Same author

Empathy and Social Attribution Skills Moderate the Relationship between Temporal Lobe Volume and Facial Expression Recognition Ability in Schizophrenia.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology·2020
Same author

Pathways to care for people with dementia: An international multicentre study.

International journal of geriatric psychiatry·2019

Related Experiment Video

Updated: Jun 22, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

Behavioral Activation and Brain Network Changes in Depression.

Minjee Jung1, Kyu-Man Han2

  • 1Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Korea.

Journal of Clinical Neurology (Seoul, Korea)
|July 2, 2024
PubMed
Summary

Behavioral activation (BA) therapy for depression shows changes in brain reward networks. These neural shifts may improve anhedonia and reduce rumination, but individual responses vary.

Keywords:
cognitive behavioral therapydepressionfunctional magnetic resonance imagingneuroimagingpsychotherapy

More Related Videos

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
08:42

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression

Published on: May 19, 2015

10.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K

Related Experiment Videos

Last Updated: Jun 22, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K
Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
08:42

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression

Published on: May 19, 2015

10.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Psychology

Background:

  • Behavioral activation (BA) is an evidence-based depression treatment.
  • Links exist between reward processing neural mechanisms and BA's effect on depressive symptoms like anhedonia.
  • Integrated interpretations of BA and reward circuitry are lacking.

Purpose of the Study:

  • To examine brain imaging studies on BA treatments.
  • To investigate how brain network changes, including reward networks, mediate BA's therapeutic effects.
  • To determine if brain circuits predict BA treatment response.

Main Methods:

  • Systematic review of brain imaging studies involving BA treatments.
  • Analysis of changes in prefrontal and subcortical reward regions.
  • Assessment of resting-state functional connectivity in the default-mode network.

Main Results:

  • Increased activation in reward-associated prefrontal and subcortical regions post-BA, linked to improved anhedonia.
  • Decreased prefrontal activation in response to sad contexts suggests disengagement from negative stimuli.
  • Reduced default-mode network connectivity may counteract depressive rumination.

Conclusions:

  • BA treatment influences reward processing and cognitive control networks.
  • Neural responses to rewards or reward pathway deficits may predict BA efficacy.
  • Personalized treatment requires understanding individual neural characteristics for optimal BA outcomes.